Cyprotex plc Stock Rating Reaffirmed by N+1 Singer (CRX)
Cyprotex plc (LON:CRX)‘s stock had its “corporate” rating reiterated by equities researchers at N+1 Singer in a research report issued on Thursday, Analyst Ratings.Net reports.
Cyprotex plc (LON:CRX) traded down 29.29% during mid-day trading on Thursday, hitting GBX 8.75. The stock had a trading volume of 2,162,365 shares. Cyprotex plc has a 52-week low of GBX 3.25 and a 52-week high of GBX 6.20. The stock’s 50-day moving average is GBX 8.21 and its 200-day moving average is GBX 6.7.
Cyprotex PLC (LON:CRX) is a holding company specializing in preclinical ADME Tox, both in vitro (laboratory experiments) and in silico (computer modelling).
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.